Agilon Health (AGL) Capital Expenditures (2020 - 2026)

Agilon Health (AGL) has 7 years of Capital Expenditures data on file, last reported at $3.1 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 19.43% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2026 stood at $12.5 million (down 10.51% YoY), and the FY2025 full-year result was $13.2 million, changed 0.07% from the prior year.
• Capital Expenditures for Q1 2026 stood at $3.1 million, up from $3.0 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $4.5 million in Q2 2022 and bottomed at $3.0 million in Q4 2025.
• The 5-year median for Capital Expenditures is $3.5 million (2022), against an average of $3.6 million.
• The widest annual swing landed in 2022, when Capital Expenditures soared 2174.72%; it then slipped 19.43% in 2026.
• A 5-year view of Capital Expenditures shows it stood at $3.5 million in 2022, then gained by 12.7% to $3.9 million in 2023, then dropped by 16.94% to $3.3 million in 2024, then decreased by 9.12% to $3.0 million in 2025, then advanced by 4.48% to $3.1 million in 2026.
• The last three Capital Expenditures figures came in at $3.1 million (Q1 2026), $3.0 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.

Peer Comparison